
New partnership looks to gene therapy for dementia
The Cell and Gene Therapy Catapult (CGT Catapult) has partnered with the UK Dementia Research Institute (UK DRI) to help advance the development of adeno-associated virus (AAV) based gene therapies for dementia. Through the collaboration, the CGT Catapult will work with UK academic centres and the UK… Read More















